| Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation M Connock, A Juarez-Garcia, S Jowett, E Frew, Z Liu, RJ Taylor, ... NIHR Health Technology Assessment programme: Executive Summaries, 2007 | 692 | 2007 |
| BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP AR Lingford-Hughes, S Welch, L Peters, DJ Nutt Journal of Psychopharmacology 26 (7), 899-952, 2012 | 305 | 2012 |
| Thiamine for Wernicke‐Korsakoff syndrome in people at risk from alcohol abuse E Day, P Bentham, R Callaghan, T Kuruvilla, S George Cochrane Database of Systematic Reviews, 2004 | 198 | 2004 |
| Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol E Day, PW Bentham, R Callaghan, T Kuruvilla, S George Cochrane Database of Systematic Reviews, 2013 | 187 | 2013 |
| Alcohol use disorders and the heart E Day, JHF Rudd Addiction 114 (9), 1670-1678, 2019 | 162 | 2019 |
| Breaking the habit: a retrospective analysis of desistance factors among formerly problematic heroin users DW Best, S Ghufran, E Day, Rajashree, J Loaring Drug and alcohol review 27 (6), 619-624, 2008 | 153 | 2008 |
| Mobile phone ownership, usage and readiness to use by patients in drug treatment J Milward, E Day, E Wadsworth, J Strang, M Lynskey Drug and alcohol dependence 146, 111-115, 2015 | 104 | 2015 |
| A comparison of stress levels, coping styles and psychological morbidity between graduate-entry and traditional undergraduate medical students during the first 2 years at a UK … R Zvauya, F Oyebode, EJ Day, CP Thomas, LA Jones BMC research notes 10, 1-10, 2017 | 103 | 2017 |
| Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. Y Adi, A Juarez-Garcia, D Wang, S Jowett, E Frew, E Day, S Bayliss, ... Health Technology Assessment (Winchester, England) 11 (6), iii-iv, 1, 2007 | 100 | 2007 |
| Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? RL Gaston, D Best, V Manning, E Day Harm Reduction Journal 6, 1-8, 2009 | 97 | 2009 |
| Implementing and evaluating social behaviour and network therapy in drug treatment practice in the UK: a feasibility study A Copello, E Williamson, J Orford, E Day Addictive Behaviors 31 (5), 802-810, 2006 | 87 | 2006 |
| Outpatient versus inpatient opioid detoxification: a randomized controlled trial E Day, J Strang Journal of Substance Abuse Treatment 40 (1), 56-66, 2011 | 79 | 2011 |
| Alcohol and substance abuse in solid-organ transplant recipients R Parker, MJ Armstrong, C Corbett, EJ Day, JM Neuberger Transplantation 96 (12), 1015-1024, 2013 | 72 | 2013 |
| First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation G Georgiou, K Webb, K Griggs, A Copello, J Neuberger, E Day Liver Transplantation 9 (7), 772-775, 2003 | 72 | 2003 |
| The hierarchy of needs and care planning in addiction services: What Maslow can tell us about addressing competing priorities? D Best, E Day, T McCarthy, I Darlington, K Pinchbeck Addiction Research & Theory 16 (4), 305-307, 2008 | 68 | 2008 |
| Inpatient versus other settings for detoxification for opioid dependence E Day, J Ison, J Strang Cochrane Database of Systematic Reviews, 2005 | 61 | 2005 |
| United Kingdom substance misuse treatment workers' attitudes toward 12-step self-help groups E Day, RL Gaston, E Furlong, V Murali, A Copello Journal of substance abuse treatment 29 (4), 321-327, 2005 | 60 | 2005 |
| Relationship between drug treatment engagement and criminal thinking style among drug-using offenders D Best, E Day, A Campbell, PM Flynn, DD Simpson European Addiction Research 15 (2), 71-77, 2009 | 58 | 2009 |
| Social network support for individuals receiving opiate substitution treatment and its association with treatment progress E Day, A Copello, M Karia, J Roche, P Grewal, S George, S Haque, ... European Addiction Research 19 (4), 211-221, 2013 | 54 | 2013 |
| Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety … J Strang, R McDonald, B Tas, E Day Addiction 111 (4), 574-582, 2016 | 53 | 2016 |
Alex CopelloProfessor of Addiction ResearchVerified email at bham.ac.uk
